Table of Contents Author Guidelines Submit a Manuscript
Journal of Pathogens
Volume 2014, Article ID 738512, 21 pages
http://dx.doi.org/10.1155/2014/738512
Review Article

Type I Diabetes Mellitus: Genetic Factors and Presumptive Enteroviral Etiology or Protection

Enterovirus Laboratory, Faculty of Medicine, Slovak Medical University, Limbova 12, 83303 Bratislava, Slovakia

Received 6 May 2014; Revised 14 July 2014; Accepted 9 November 2014; Published 10 December 2014

Academic Editor: Alexander Rodriguez-Palacios

Copyright © 2014 Jana Precechtelova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. S. Papaspyros, “The history of diabetes,” in The History of Diabetes Mellitus, G. T. Verlag, Ed., p. 4, Thieme, Stuttgart, Germany, 1964. View at Google Scholar
  2. http://www.crystalinks.com/egyptmedicine.html.
  3. J. Zajac, A. Shrestha, P. Patel, and L. Poretsky, “The main events in the history of diabetes mellitus,” in Principles of Diabetes Mellitus, L. Poretsky, Ed., pp. 3–16, Springer, New York, NY, USA, 2nd edition, 2010. View at Publisher · View at Google Scholar
  4. F. Allen, “Studies concerning diabetes,” Journal of American Medical Association, vol. 63, pp. 939–943, 1914. View at Google Scholar
  5. http://www.nobelprize.org/nobel_prizes/medicine/.
  6. H. P. Himsworth, “The mechanism of diabetes mellitus,” The Lancet, vol. 234, no. 6047, pp. 171–176, 1939. View at Publisher · View at Google Scholar · View at Scopus
  7. American Diabetes Association, “Standards of medical care in diabetes—2014,” Diabetes Care, vol. 37, no. 1, pp. 14–80, 2014. View at Publisher · View at Google Scholar
  8. World Health Organization, “Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy,” WHO/NMH/MND/13.2, World Health Organization, 2013. View at Google Scholar
  9. “Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia,” Report of a WHO/IDF Consultation, 2006.
  10. W. Gepts, “Pathologic anatomy of the pancreas in juvenile diabetes mellitus.,” Diabetes, vol. 14, no. 10, pp. 619–633, 1965. View at Google Scholar · View at Scopus
  11. A. K. Foulis, C. N. Liddle, M. A. Farquharson, J. A. Richmond, and R. S. Weir, “The histopathology of the pancreas in type I (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom,” Diabetologia, vol. 29, no. 5, pp. 267–274, 1986. View at Publisher · View at Google Scholar · View at Scopus
  12. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 36, no. 1, pp. 67–74, 2013. View at Publisher · View at Google Scholar
  13. S. Baekkeskov, H.-J. Aanstoot, S. Christgau et al., “Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase,” Nature, vol. 347, no. 6289, pp. 151–156, 1990. View at Publisher · View at Google Scholar · View at Scopus
  14. J. P. Palmer, C. M. Asplin, P. Clemons et al., “Insulin antibodies in insulin-dependent diabetics before insulin treatment,” Science, vol. 222, no. 4630, pp. 1337–1339, 1983. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Bonifacio, V. Lampasona, S. Genovese, M. Ferrari, and E. Bosi, “Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies,” The Journal of Immunology, vol. 155, no. 11, pp. 5419–5426, 1995. View at Google Scholar · View at Scopus
  16. J. Lu, Q. Li, H. Xie et al., “Identification of a second transmembrane protein tyrosine phosphatase, IA-2β, as an autoantigen in insulin-dependent diabetes mellitus: Precursor of the 37-kDa tryptic fragment,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 6, pp. 2307–2311, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Pietropaolo, L. Castaño, S. Babu et al., “Islet cell autoantigen 69 kD (ICA69): molecular cloning and characterization of a novel diabetes-associated autoantigen,” The Journal of Clinical Investigation, vol. 92, no. 1, pp. 359–371, 1993. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Castaño, E. Russo, L. Zhou, M. A. Lipes, and G. S. Eisenbarth, “Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes,” Journal of Clinical Endocrinology and Metabolism, vol. 73, no. 6, pp. 1197–1201, 1991. View at Publisher · View at Google Scholar · View at Scopus
  19. R. C. Nayak, M. A. Omar, A. Rabizadeh, S. Srikanta, and G. S. Eisenbarth, ““Cytoplasmic” islet cell antibodies. Evidence that the target antigen is a sialoglycoconjugate,” Diabetes, vol. 34, no. 6, pp. 617–619, 1985. View at Publisher · View at Google Scholar · View at Scopus
  20. S. D. Arden, B. O. Roep, P. I. Neophytou et al., “Imogen 38: a novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient,” The Journal of Clinical Investigation, vol. 97, no. 2, pp. 551–561, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Kasimiotis, M. A. Myers, A. Argentaro et al., “Sex-determining region Y-related protein SOX13 is a diabetes autoantigen expressed in pancreatic islets,” Diabetes, vol. 49, no. 4, pp. 555–561, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. J. M. Wenzlau, K. Juhl, L. Yu et al., “The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 43, pp. 17040–17045, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Kimpimäki, A. Kupila, A.-M. Hämäläinen et al., “The first signs of β-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the finnish type 1 diabetes prediction and prevention study,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 10, pp. 4782–4788, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. C. F. Verge, R. Gianani, E. Kawasaki et al., “Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies,” Diabetes, vol. 45, no. 3, pp. 926–933, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. G. F. Bottazzo, A. F. Christensen, and D. Doniach, “Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies,” The Lancet, vol. 2, no. 7892, pp. 1279–1283, 1974. View at Google Scholar · View at Scopus
  26. D. P. Singal and M. A. Blajchman, “Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus,” Diabetes, vol. 22, no. 6, pp. 429–432, 1973. View at Google Scholar · View at Scopus
  27. A. G. Cudworth and J. C. Woodrow, “Letter: HL-A antigens and diabetes mellitus,” The Lancet, vol. 2, no. 7889, article 1153, 1974. View at Google Scholar · View at Scopus
  28. L. Zhang and G. S. Eisenbarth, “Prediction and prevention of type 1 diabetes mellitus,” Journal of Diabetes, vol. 3, no. 1, pp. 48–57, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. D. J. Smyth, J. D. Cooper, R. Bailey et al., “A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region,” Nature Genetics, vol. 38, no. 6, pp. 617–619, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. Genomes Project Consortium, “A map of human genome variation from population-scale sequencing,” Nature, vol. 467, no. 7319, pp. 1061–1073, 2010. View at Publisher · View at Google Scholar
  31. I. Kockum, C. B. Sanjeevi, S. Eastman, M. Landin-Olsson, G. Dahlquist, and Å. Lernmark, “Complex interaction between HLA DR and DQ in conferring risk for childhood type 1 diabetes,” European Journal of Immunogenetics, vol. 26, no. 5, pp. 361–372, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. B. P. C. Koeleman, B. A. Lie, D. E. Undlien et al., “Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease,” Genes and Immunity, vol. 5, no. 5, pp. 381–388, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. O. L. Griffith, S. B. Montgomery, B. Bernier et al., “ORegAnno: an open-access community-driven resource for regulatory annotation,” Nucleic Acids Research, vol. 36, no. 1, pp. D107–D113, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. J. K. Distefano and D. M. Taverna, “Technological issues and experimental design of gene association studies,” Methods in Molecular Biology, vol. 700, pp. 3–16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. H. A. Erlich, A. M. Valdes, S. L. McDevitt et al., “Next generation sequencing reveals the association of DRB3*02:02 with type 1 diabetes,” Diabetes, vol. 62, no. 7, pp. 2618–2622, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. G. D. Snell and G. F. Higgins, “Alleles at the histocompatibility-2 locus in the mouse as determined by tumor transplantation,” Genetics, vol. 36, no. 3, pp. 306–310, 1951. View at Google Scholar · View at Scopus
  37. J. A. Noble and H. A. Erlich, “Genetics of type 1 diabetes,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 1, Article ID a007732, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. I. Santin and D. L. Eizirik, “Candidate genes for type 1 diabetes modulate pancreatic islet inflammation and β-cell apoptosis,” Diabetes, Obesity and Metabolism, vol. 15, no. 3, pp. 71–81, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. The MHC sequencing consortium, “Complete sequence and gene map of a human major histocompatibility complex,” Nature, vol. 401, no. 6756, pp. 921–923, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Mach, V. Steimle, E. Martinez-Soria, and W. Reith, “Regulation of MHC class II genes: lessons from a disease,” Annual Review of Immunology, vol. 14, pp. 301–331, 1996. View at Publisher · View at Google Scholar · View at Scopus
  41. V. Radha, K. S. Vimaleswaran, R. Deepa, and V. Mohan, “The genetics of diabetes mellitus,” Indian Journal of Medical Research, vol. 117, pp. 225–238, 2003. View at Google Scholar · View at Scopus
  42. H. A. Erlich, R. L. Griffith, T. L. Bugawan, R. Ziegler, C. Alper, and G. Eisenbarth, “Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with novel HLA-DQB1 allele and unusual DR2 and DR1 haplotypes,” Diabetes, vol. 40, no. 4, pp. 478–481, 1991. View at Publisher · View at Google Scholar · View at Scopus
  43. D. J. Penn, “Major Histocompatibility Complex (MHC),” in Encyclopedia of Life Sciences, Macmillan Publishers Ltd, Nature Publishing Group, 2002. View at Publisher · View at Google Scholar
  44. J. R. Gruen and S. M. Weissman, “Human MHC class III and IV genes and disease associations,” Frontiers in Bioscience, vol. 6, pp. D960–D972, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Bell, “Perinatal diagnosis current approaches and future trends,” in Human Genetic Information: Science, Law and Ethics, CIBA Foundation Symposium 149, pp. 18–36, John Wiley & Sons, Chichester, UK, 1990. View at Google Scholar
  46. R. Redon, S. Ishikawa, K. R. Fitch et al., “Global variation in copy number in the human genome,” Nature, vol. 444, no. 7118, pp. 444–454, 2006. View at Publisher · View at Google Scholar
  47. R. Tisch and H. McDevitt, “Insulin-dependent diabetes mellitus,” Cell, vol. 85, no. 3, pp. 291–297, 1996. View at Publisher · View at Google Scholar · View at Scopus
  48. E.-P. Reich, H. von Grafenstein, A. Barlow, K. E. Swenson, K. Williams, and C. A. Janeway Jr., “Self peptides isolated from MHC glycoproteins of non-obese diabetic mice,” The Journal of Immunology, vol. 152, no. 5, pp. 2279–2288, 1994. View at Google Scholar · View at Scopus
  49. A. P. Lambert, K. M. Gillespie, G. Thomson et al., “Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 8, pp. 4037–4043, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. J. A. Noble, A. M. Valdes, M. Cook, W. Klitz, G. Thomson, and H. A. Erlich, “The role of HLA class II genes in insulin-dependent diabetes mellitus: Molecular analysis of 180 Caucasian, multiplex families,” American Journal of Human Genetics, vol. 59, no. 5, pp. 1134–1148, 1996. View at Google Scholar · View at Scopus
  51. J. C. Gorga and D. Monos, “HLA and disease: molecular basis,” in MHC Molecules: Expression, Assembly and Function, J. C. Gorga, Ed., pp. 135–162, Springer eBook, R. G. Landes Company, Austin, Tex, USA, 1996. View at Google Scholar
  52. R. Horton, R. Gibson, P. Coggill et al., “Variation analysis and gene annotation of eight MHC haplotypes: the MHC Haplotype project,” Immunogenetics, vol. 60, no. 1, pp. 1–18, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. D. F. Conrad, T. D. Andrews, N. P. Carter, M. E. Hurles, and J. K. Pritchard, “A high-resolution survey of deletion polymorphism in the human genome,” Nature Genetics, vol. 38, no. 1, pp. 75–81, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Beyan, R. C. Drexhage, L. V. D. H. Nieuwenhuijsen et al., “Monocyte gene-expression profiles associated with childhood-onset type 1 diabetes and disease risk: a study of identical twins,” Diabetes, vol. 59, no. 7, pp. 1751–1755, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. C. Sapienza and J. G. Hall, “Genetic imprinting in human disease,” in The Metabolic and Molecular Bases of Inherited Disease, C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, Eds., vol. 1, chapter 7, pp. 437–458, McGraw-Hill, New York, NY, USA, 7th edition, 1995. View at Google Scholar
  56. J. H. Warram, A. S. Krolewski, M. S. Gottlieb, and C. R. Kahn, “Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers,” The New England Journal of Medicine, vol. 311, no. 3, pp. 149–152, 1984. View at Publisher · View at Google Scholar · View at Scopus
  57. H. Tillil and J. Kobberling, “Age-corrected empirical genetic risk estimates for first-degree relatives of IDDM patients,” Diabetes, vol. 36, no. 1, pp. 93–99, 1987. View at Publisher · View at Google Scholar · View at Scopus
  58. D. Bleich, M. Polak, G. S. Eisenbarth, and R. A. Jackson, “Decreased risk of type I diabetes in offspring of mothers who acquire diabetes during adrenarchy,” Diabetes, vol. 42, no. 10, pp. 1433–1439, 1993. View at Publisher · View at Google Scholar · View at Scopus
  59. L. Yu, H. P. Chase, A. Falorni, M. Rewers, Å. Lernmark, and G. S. Eisenbarth, “Sexual dimorphism in transmission of expression of islet autoantibodies to offspring,” Diabetologia, vol. 38, no. 11, pp. 1353–1357, 1995. View at Publisher · View at Google Scholar · View at Scopus
  60. C. Wallace, D. J. Smyth, M. Maisuria-Armer, N. M. Walker, J. A. Todd, and D. G. Clayton, “The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes,” Nature Genetics, vol. 42, no. 1, pp. 68–71, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. V. K. Rakyan, H. Beyan, T. A. Down et al., “Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis,” PLoS Genetics, vol. 7, no. 9, Article ID e1002300, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Nerup, P. Platz, O. O. Andersen et al., “HL A antigens and diabetes mellitus,” The Lancet, vol. 2, no. 7885, pp. 864–866, 1974. View at Publisher · View at Google Scholar · View at Scopus
  63. G. I. Bell, S. Horita, and J. H. Karam, “A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus,” Diabetes, vol. 33, no. 2, pp. 176–183, 1984. View at Publisher · View at Google Scholar · View at Scopus
  64. L. Nisticò, R. Buzzetti, L. E. Pritchard et al., “The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian diabetes registry,” Human Molecular Genetics, vol. 5, no. 7, pp. 1075–1080, 1996. View at Publisher · View at Google Scholar · View at Scopus
  65. N. Bottini, L. Musumeci, A. Alonso et al., “A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes,” Nature Genetics, vol. 36, no. 4, pp. 337–338, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. A. Vella, J. D. Cooper, C. E. Lowe et al., “Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms,” American Journal of Human Genetics, vol. 76, no. 5, pp. 773–779, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Bakay, R. Pandey, and H. Hakonarson, “Genes involved in type 1 diabetes: an update,” Genes, vol. 4, no. 4, pp. 499–521, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. S. Nejentsev, N. Walker, D. Riches, M. Egholm, and J. A. Todd, “Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes,” Science, vol. 324, no. 5925, pp. 387–389, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. M. Heinig, E. Petretto, C. Wallace, and S. A. Cook, “A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk,” Nature, vol. 467, no. 7314, pp. 460–464, 2010. View at Publisher · View at Google Scholar
  70. H. Hakonarson, S. F. A. Grant, J. P. Bradfield et al., “A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene,” Nature, vol. 448, no. 7153, pp. 591–594, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. J. A. Todd, N. M. Walker, J. D. Cooper et al., “Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes,” Nature Genetics, vol. 39, no. 7, pp. 857–864, 2007. View at Publisher · View at Google Scholar
  72. The Wellcome Trust Case Control Consortium, “Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls,” Nature, vol. 447, no. 7145, pp. 661–678, 2007. View at Publisher · View at Google Scholar
  73. J. D. Cooper, D. J. Smyth, A. M. Smiles et al., “Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci,” Nature Genetics, vol. 40, no. 12, pp. 1399–1401, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. D. J. Smyth, V. Plagnol, N. M. Walker et al., “Shared and distinct genetic variants in type 1 diabetes and celiac disease,” The New Englend Journal of Medicine, vol. 359, no. 26, pp. 2767–2777, 2008. View at Publisher · View at Google Scholar
  75. J. C. Barrett, D. G. Clayton, P. Concannon et al., “Type 1 Diabetes Genetics Consortium. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes,” Nature Genetics, vol. 41, no. 6, pp. 703–707, 2009. View at Publisher · View at Google Scholar
  76. S. F. Grant, H. Q. Qu, J. P. Bradfield et al., “Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes,” Diabetes, vol. 58, no. 1, pp. 290–295, 2009. View at Publisher · View at Google Scholar
  77. C. Wallace, D. J. Smyth, M. Maisuria-Armer, N. M. Walker, J. A. Todd, and D. G. Clayton, “The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes,” Nature Genetics, vol. 42, no. 1, pp. 68–71, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. J. P. Bradfield, H. Q. Qu, and K. Wang, “A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci,” PLoS Genetics, vol. 7, no. 9, Article ID e1002293, 2011. View at Publisher · View at Google Scholar
  79. V. Plagnol, J. M. M. Howson, D. J. Smyth et al., “Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases,” PLoS Genetics, vol. 7, no. 8, Article ID e1002216, 2006. View at Publisher · View at Google Scholar
  80. T. Bazzaz, M. M. Amoli, Z. Taheri et al., “TNF-α and IFN-γ gene variation and genetic susceptibility to type 1 diabetes and its microangiopathic complications,” Journal of Diabetes and Metabolic Disorders, vol. 13, p. 46, 2014. View at Publisher · View at Google Scholar
  81. http://www.t1dbase.org/page/Regions.
  82. W.-C. G. Yeung, W. D. Rawlinson, and M. E. Craig, “Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies,” British Medical Journal, vol. 342, no. 7794, article d35, 2011. View at Publisher · View at Google Scholar · View at Scopus
  83. A. D. Paterson, “Genetic epidemiology of type 1 diabetes,” Current Diabetes Reports, vol. 6, no. 2, pp. 139–146, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. Y.-H. Qiu, F.-Y. Deng, M.-J. Li, and S.-F. Lei, “Identification of novel risk genes associated with type 1 diabetes mellitus using a genome-wide gene-based association analysis,” Journal of Diabetes Investigation, 2014. View at Publisher · View at Google Scholar · View at Scopus
  85. C. J. Fox and J. S. Danska, “Independent genetic regulation of T-cell and antigen-presenting cell participation in autoimmune islet inflammation,” Diabetes, vol. 47, no. 3, pp. 331–338, 1998. View at Publisher · View at Google Scholar · View at Scopus
  86. P. L. Kendall, G. Yu, E. J. Woodward, and J. W. Thomas, “Tertiary lymphoid structures in the pancreas promote selection of B lymphocytes in autoimmune diabetes,” The Journal of Immunology, vol. 178, no. 9, pp. 5643–5651, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. A. Willcox, S. J. Richardson, A. J. Bone, A. K. Foulis, and N. G. Morgan, “Analysis of islet inflammation in human type 1 diabetes,” Clinical and Experimental Immunology, vol. 155, no. 2, pp. 173–181, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. T. Habib, A. Funk, M. Rieck et al., “Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant,” The Journal of Immunology, vol. 188, no. 1, pp. 487–496, 2012. View at Publisher · View at Google Scholar · View at Scopus
  89. W. S. Thompson, M. Pekalski, H. Z. Simons et al., “Multi-parametric flow cytometric and genetic investigation of peripheral B-cell compartment in human type 1 diabetes,” Clinical and Experimental Immunology, vol. 177, no. 3, pp. 571–585, 2014. View at Publisher · View at Google Scholar
  90. M. Yang, K. Rui, S. Wang, and L. Lu, “Regulatory B cells in autoimmune diseases,” Cellular and Molecular Immunology, vol. 10, no. 2, pp. 122–132, 2013. View at Publisher · View at Google Scholar · View at Scopus
  91. K. Schroder, P. J. Hertzog, T. Ravasi, and D. A. Hume, “Interferon-γ: an overview of signals, mechanisms and functions,” Journal of Leukocyte Biology, vol. 75, no. 2, pp. 163–189, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. http://www.phgfoundation.org/news/4515.
  93. C. Guiducci, M. Gong, Z. Xu et al., “TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus,” Nature, vol. 465, no. 7300, pp. 937–941, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. A. Rabinovitch, “An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus,” Diabetes/Metabolism Reviews, vol. 14, no. 2, pp. 129–151, 1998. View at Publisher · View at Google Scholar
  95. A. K. Foulis, M. A. Farquharson, and A. Meager, “Immunoreactive α-interferon in insulin-secreting β cells in type 1 diabetes mellitus,” The Lancet, vol. 2, no. 8573, pp. 1423–1427, 1987. View at Google Scholar · View at Scopus
  96. G. C. Toms, P. Baker, and B. J. Boucher, “The production of immunoreactive α- and γ-interferon by circulating mononuclear cells in type 1 diabetes,” Diabetic Medicine, vol. 8, no. 6, pp. 547–550, 1991. View at Publisher · View at Google Scholar · View at Scopus
  97. W. Chehadeh, J. Kerr-Conte, F. Pattou et al., “Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in β cells,” Journal of Virology, vol. 74, no. 21, pp. 10153–10164, 2000. View at Publisher · View at Google Scholar · View at Scopus
  98. X. Li, S. Leung, S. Qureshi, J. E. Darnell Jr., and G. R. Stark, “Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-α,” The Journal of Biological Chemistry, vol. 271, no. 10, pp. 5790–5794, 1996. View at Publisher · View at Google Scholar · View at Scopus
  99. A. Takaoka, Y. Mitani, H. Suemori et al., “Cross talk between interferon-γ and -α/β signaling components in caveolar membrane domains,” Science, vol. 288, no. 5475, pp. 2357–2360, 2000. View at Publisher · View at Google Scholar · View at Scopus
  100. M. Giroux, M. Schmidt, and A. Descoteaux, “IFN-γ-induced MHC class II expression: transactivation of class II transactivator promoter IV by IFN regulatory factor-1 is regulated by protein kinase C-α,” The Journal of Immunology, vol. 171, no. 8, pp. 4187–4194, 2003. View at Publisher · View at Google Scholar · View at Scopus
  101. K. Lind, S. J. Richardson, P. Leete, N. G. Morgan, O. Korsgren, and M. Flodström-Tullberga, “Induction of an antiviral state and attenuated coxsackievirus replication in type III interferon-treated primary human pancreatic islets,” Journal of Virology, vol. 87, no. 13, pp. 7646–7654, 2013. View at Publisher · View at Google Scholar · View at Scopus
  102. C. Y. Pak, R. G. McArthur, H.-M. Eun, and J.-W. Yoon, “Association of cytomegalovirus infection with autoimmune type 1 diabetes,” The Lancet, vol. 332, no. 8601, pp. 1–4, 1988. View at Publisher · View at Google Scholar · View at Scopus
  103. H. S. Hiemstra, N. C. Schloot, P. A. van Veelen et al., “Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 7, pp. 3988–3991, 2001. View at Publisher · View at Google Scholar · View at Scopus
  104. M. Sester, U. Sester, B. C. Gärtner, M. Girndt, A. Meyerhans, and H. Köhler, “Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection,” Journal of the American Society of Nephrology, vol. 13, no. 10, pp. 2577–2584, 2002. View at Publisher · View at Google Scholar · View at Scopus
  105. A. Kasuga, R. Harada, and T. Saruta, “Insulin-dependent diabetes mellitus associated with parvovirus B19 infection,” Annals of Internal Medicine, vol. 125, no. 8, pp. 700–701, 1996. View at Google Scholar · View at Scopus
  106. P. Vigeant, H. A. Menard, and G. Boire, “Chronic modulation of the autoimmune response following parvovirus B19 infection,” Journal of Rheumatology, vol. 21, no. 6, pp. 1165–1167, 1994. View at Google Scholar · View at Scopus
  107. M. C. Honeyman, N. L. Stone, B. A. Falk, G. Nepom, and L. C. Harrison, “Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens,” Journal of Immunology, vol. 184, no. 4, pp. 2204–2210, 2010. View at Publisher · View at Google Scholar · View at Scopus
  108. F. Ginsberg-Fellner, M. E. Witt, S. Yagihashi et al., “Congenital rubella syndrome as a model for Type 1 (insulin-dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies,” Diabetologia, vol. 27, no. 1, pp. 87–89, 1984. View at Publisher · View at Google Scholar · View at Scopus
  109. D. Ou, L. A. Mitchell, D. L. Metzger, S. Gillam, and A. J. Tingle, “Cross-reactive rubella virus and glutamic acid decarboxylase (65 and 67) protein determinants recognised by T cells of patients with type I diabetes mellitus,” Diabetologia, vol. 43, no. 6, pp. 750–762, 2000. View at Publisher · View at Google Scholar · View at Scopus
  110. M. G. Cavallo, M. G. Baroni, A. Toto et al., “Viral infection induces cytokine release by beta islet cells,” Immunology, vol. 75, no. 4, pp. 664–668, 1992. View at Google Scholar · View at Scopus
  111. H. Hyoty, P. Parkkonen, M. Rode, O. Bakke, and P. Leinikki, “Common peptide epitope in mumps virus nucleocapsid protein and MHC class II-associated invariant chain,” Scandinavian Journal of Immunology, vol. 37, no. 5, pp. 550–558, 1993. View at Publisher · View at Google Scholar · View at Scopus
  112. B. Conrad, R. N. Weissmahr, J. Böni, R. Arcari, J. Schüpbach, and B. Mach, “A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes,” Cell, vol. 90, no. 2, pp. 303–313, 1997. View at Publisher · View at Google Scholar · View at Scopus
  113. G. Tapia, O. Cinek, T. Rasmussen, B. Grinde, L. C. Stene, and K. S. Rønningen, “Longitudinal study of parechovirus infection in infancy and risk of repeated positivity for multiple islet autoantibodies: the MIDIA study,” Pediatric Diabetes, vol. 12, no. 1, pp. 58–62, 2011. View at Publisher · View at Google Scholar · View at Scopus
  114. G. R. Vreugdenhil, N. C. Schloot, A. Hoorens et al., “Acute onset of type I diabetes mellitus after severe echovirus 9 infection: putative pathogenic pathways,” Clinical Infectious Diseases, vol. 31, no. 4, pp. 1025–1031, 2000. View at Publisher · View at Google Scholar · View at Scopus
  115. J. W. Yoon, T. Onodera, and A. L. Notkins, “Virus-induced diabetes mellitus. XV. Beta cell damage and insulin-dependent hyperglycemia in mice infected with coxsackie virus B4,” The Journal of Experimental Medicine, vol. 148, no. 4, pp. 1068–1080, 1978. View at Publisher · View at Google Scholar · View at Scopus
  116. M. Lonnrot, K. Salminen, and M. Knip, “Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: a prospective study. Childhood Diabetes in Finland (DiMe) Study Group,” Journal of Medical Virology, vol. 61, no. 2, pp. 214–220, 2000. View at Publisher · View at Google Scholar
  117. D. V. Serreze, E. W. Ottendorfer, T. M. Elliss, C. J. Gauntt, and M. A. Atkinson, “Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets,” Diabetes, vol. 49, no. 5, pp. 708–711, 2000. View at Publisher · View at Google Scholar · View at Scopus
  118. M. S. Horwitz, L. M. Bradley, J. Harbertson, T. Krahl, J. Lee, and N. Sarvetnick, “Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry,” Nature Medicine, vol. 4, no. 7, pp. 781–785, 1998. View at Publisher · View at Google Scholar · View at Scopus
  119. A. Willcox, S. J. Richardson, A. J. Bone, A. K. Foulis, and N. G. Morgan, “Immunohistochemical analysis of the relationship between islet cell proliferation and the production of the enteroviral capsid protein, VP1, in the islets of patients with recent-onset type 1 diabetes,” Diabetologia, vol. 54, no. 9, pp. 2417–2420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  120. B. M. Schulte, M. Kramer, M. Ansems et al., “Phagocytosis of enterovirus-infected pancreatic β-cells triggers innate immune responses in human dendritic cells,” Diabetes, vol. 59, no. 5, pp. 1182–1191, 2010. View at Publisher · View at Google Scholar · View at Scopus
  121. F. Brilot, V. Geenen, D. Hober, and C. A. Stoddart, “Coxsackievirus B4 infection of human fetal thymus cells,” Journal of Virology, vol. 78, no. 18, pp. 9854–9861, 2004. View at Publisher · View at Google Scholar · View at Scopus
  122. M. Oikarinen, S. Tauriainen, T. Honkanen et al., “Detection of enteroviruses in the intestine of type 1 diabetic patients,” Clinical and Experimental Immunology, vol. 151, no. 1, pp. 71–75, 2008. View at Publisher · View at Google Scholar · View at Scopus
  123. I. S. Yap, G. Giddings, E. Pocock, and J. K. Chantler, “Lack of islet neogenesis plays a key role in beta-cell depletion in mice infected with a diabetogenic variant of coxsackievirus B4,” Journal of General Virology, vol. 84, no. 11, pp. 3051–3068, 2003. View at Publisher · View at Google Scholar · View at Scopus
  124. K. P. Ward, W. H. Galloway, and I. A. Auchterlonie, “Congenital cytomegalovirus infection and diabetes,” The Lancet, vol. 1, no. 8114, article 497, 1979. View at Google Scholar · View at Scopus
  125. C. Y. Pak, C. Y. Cha, R. V. Rajotte, R. G. McArthur, and J. W. Yoon, “Human pancreatic islet cell specific 38 kilodalton autoantigen identified by cytomegalovirus-induced monoclonal islet cell autoantibody,” Diabetologia, vol. 33, no. 9, pp. 569–572, 1990. View at Publisher · View at Google Scholar · View at Scopus
  126. K. Numazaki, H. Goldman, I. Wong, and M. A. Wainberg, “Viral infection of human fetal islets of Langerhans. Replication of human cytomegalovirus in cultured human fetal pancreatic islets,” American Journal of Clinical Pathology, vol. 90, no. 1, pp. 52–57, 1988. View at Google Scholar · View at Scopus
  127. M. J. Smelt, M. M. Faas, B. J. de Haan et al., “Rat pancreatic beta cells and cytomegalovirus infection,” Pancreas, vol. 39, no. 1, pp. 47–56, 2010. View at Publisher · View at Google Scholar
  128. J. Aarnisalo, R. Veijola, R. Vainionpää, O. Simell, M. Knip, and J. Ilonen, “Cytomegalovirus infection in early infancy: risk of induction and progression of autoimmunity associated with type 1 diabetes,” Diabetologia, vol. 51, no. 5, pp. 769–772, 2008. View at Publisher · View at Google Scholar · View at Scopus
  129. S.-A. Ivarsson, B. Lindberg, K. O. Nilsson, K. Ahlfors, and L. Svanberg, “The prevalence of type 1 diabetes mellitus at follow-up of Swedish infants congenitally infected with cytomegalovirus,” Diabetic Medicine, vol. 10, no. 6, pp. 521–523, 1993. View at Publisher · View at Google Scholar · View at Scopus
  130. A. K. Foulis, M. McGill, M. A. Farquharson, and D. A. Hilton, “A search for evidence of viral infection in pancreases of newly diagnosed patients with IDDM,” Diabetologia, vol. 40, no. 1, pp. 53–61, 1997. View at Publisher · View at Google Scholar · View at Scopus
  131. N. Itoh, T. Hanafusa, K. Yamagata et al., “No detectable cytomegalovirus and Epstein-Barr virus genomes in the pancreas of recent-onset IDDM patients,” Diabetologia, vol. 38, no. 6, pp. 667–671, 1995. View at Publisher · View at Google Scholar · View at Scopus
  132. Y. Munakata, T. Kodera, T. Saito, and T. Sasaki, “Rheumatoid arthritis, type 1 diabetes, and Graves' disease after acute parvovirus B19 infection,” The Lancet, vol. 366, no. 9487, article 780, 2005. View at Publisher · View at Google Scholar · View at Scopus
  133. A. von Poblotzki, C. Gerdes, U. Reischl, H. Wolf, and S. Modrow, “Lymphoproliferative responses after infection with human parvovirus B19,” Journal of Virology, vol. 70, no. 10, pp. 7327–7330, 1996. View at Google Scholar · View at Scopus
  134. D. Zipris, J.-L. Hillebrands, R. M. Welsh et al., “Infections that induce autoimmune diabetes in BBDR rats modulate CD4+CD25+ T cell populations,” The Journal of Immunology, vol. 170, no. 7, pp. 3592–3602, 2003. View at Publisher · View at Google Scholar · View at Scopus
  135. D. Zipris, E. Lien, J. X. Xie, D. L. Greiner, J. P. Mordes, and A. A. Rossini, “TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats,” The Journal of Immunology, vol. 174, no. 1, pp. 131–142, 2005. View at Publisher · View at Google Scholar · View at Scopus
  136. M. C. Honeyman, B. S. Coulson, N. L. Stone et al., “Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes,” Diabetes, vol. 49, no. 8, pp. 1319–1324, 2000. View at Publisher · View at Google Scholar · View at Scopus
  137. K. L. Graham, N. Sanders, Y. Tan, J. Allison, T. W. H. Kay, and B. S. Coulson, “Rotavirus infection accelerates type 1 diabetes in mice with established insulitis,” Journal of Virology, vol. 82, no. 13, pp. 6139–6149, 2008. View at Publisher · View at Google Scholar · View at Scopus
  138. J. A. Pane, N. L. Webster, and B. S. Coulson, “Rotavirus activates lymphocytes from non-obese diabetic mice by triggering toll-like receptor 7 signaling and interferon production in plasmacytoid dendritic cells,” PLoS Pathogens, vol. 10, no. 3, Article ID e1003998, 2014. View at Publisher · View at Google Scholar · View at Scopus
  139. E. A. M. Gale, “Congenital rubella: citation virus or viral cause of type 1 diabetes?” Diabetologia, vol. 51, no. 9, pp. 1559–1566, 2008. View at Publisher · View at Google Scholar · View at Scopus
  140. B. Lindberg, K. Ahlfors, A. Carlsson et al., “Previous exposure to measles, mumps, and rubella—but not vaccination during adolescence—correlates to the prevalence of pancreatic and thyroid autoantibodies,” Pediatrics, vol. 104, no. 1, article e12, 1999. View at Publisher · View at Google Scholar · View at Scopus
  141. F. Ramondetti, S. Sacco, M. Comelli et al., “Type 1 diabetes and measles, mumps and rubella chilhood infections within the Italian Insulin dependent diabetes regitstry,” Diabetic Medicine, vol. 29, no. 6, pp. 761–766, 2011. View at Publisher · View at Google Scholar
  142. P. Parkkonen, H. Hyoty, L. Koskinen, and P. Leinikki, “Mumps virus infects Beta cells in human fetal islet cell cultures upregulating the expression of HLA class I molecules,” Diabetologia, vol. 35, no. 1, pp. 63–69, 1992. View at Publisher · View at Google Scholar · View at Scopus
  143. K. Helmke, A. Otten, and W. Willems, “Islet cell antibodies in children with mumps infection,” The Lancet, vol. 2, no. 8187, pp. 211–212, 1980. View at Google Scholar · View at Scopus
  144. H. Hyoty, M. Hiltunen, A. Reunanen et al., “Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland,” Diabetologia, vol. 36, no. 12, pp. 1303–1308, 1993. View at Publisher · View at Google Scholar · View at Scopus
  145. R. Löwer, J. Löwer, and R. Kurth, “The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 11, pp. 5177–5184, 1996. View at Publisher · View at Google Scholar · View at Scopus
  146. E. Balada, M. Vilardell-Tarrés, and J. Ordi-Ros, “Implication of human endogenous retroviruses in the development of autoimmune diseases,” International Reviews of Immunology, vol. 29, no. 4, pp. 351–370, 2010. View at Publisher · View at Google Scholar · View at Scopus
  147. M. S. Oberste, E. Gotuzzo, P. Blair et al., “Human febrile illness caused by encephalomyocarditis virus infection, peru,” Emerging Infectious Diseases, vol. 15, no. 4, pp. 640–646, 2009. View at Publisher · View at Google Scholar · View at Scopus
  148. S. Nagafuchi, M. Teshima, Y. Kai et al., “The significance of tyrosine kinase 2 gene in encephalomyocarditis-D virus-induced diabetes as studied in Tyk2 gene knockout mice (P6334),” Journal of Immunology, vol. 190, pp. 182–119, 2013, (Meeting Abstract Supplement). View at Google Scholar
  149. B. Niklasson, K. E. Heller, B. Schønecker et al., “Development of type 1 diabetes in wild bank voles associated with islet autoantibodies the novel Ljungan virus,” Experimental Diabesity Research, vol. 4, no. 1, pp. 35–44, 2003. View at Publisher · View at Google Scholar · View at Scopus
  150. M. Roivainen, P. Ylipaasto, C. Savolainen, J. Galama, T. Hovi, and T. Otonkoski, “Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains,” Diabetologia, vol. 45, no. 5, pp. 693–702, 2002. View at Publisher · View at Google Scholar · View at Scopus
  151. E. Cabrera-Rode, L. Sarmiento, C. Tiberti et al., “Type 1 diabetes islet associated antibodies in subjects infected by echovirus 16,” Diabetologia, vol. 46, no. 10, pp. 1348–1353, 2003. View at Publisher · View at Google Scholar · View at Scopus
  152. E. Cabrera-Rode, L. Sarmiento, G. Molina et al., “Islet cell related antibodies and type 1 diabetes associated with echovirus 30 epidemic: a case report,” Journal of Medical Virology, vol. 76, no. 3, pp. 373–377, 2005. View at Publisher · View at Google Scholar · View at Scopus
  153. O. Diaz-Horta, L. Sarmiento, A. Baj, E. Cabrera-Rode, and A. Toniolo, “Echovirus epidemics, autoimmunity, and type 1 diabetes,” in Type 1 Diabetes - Pathogenesis, Genetics and Immunotherapy, D. Wagner, Ed., pp. 211–230, InTech, 2011, http://www.intechopen.com/books/type-1-diabetes-pathogenesis-genetics-and-immunotherapy/echovirus-epidemics-autoimmunity-and-type-1-diabetes. View at Publisher · View at Google Scholar
  154. H. Hyoty and K. W. Taylor, “The role of viruses in human diabetes,” Diabetologia, vol. 45, no. 10, pp. 1353–1361, 2002. View at Publisher · View at Google Scholar
  155. T. Otonkoski, M. Roivainen, O. Vaarala et al., “Neonatal Type I diabetes associated with maternal echovirus 6 infection: a case report,” Diabetologia, vol. 43, no. 10, pp. 1235–1238, 2000. View at Publisher · View at Google Scholar · View at Scopus
  156. Ç. H. Williams, S. Oikarinen, S. Tauriainen, K. Salminen, H. Hyöty, and G. Stanway, “Molecular analysis of an echovirus 3 strain isolated from an individual concurrently with appearance of islet cell and IA-2 autoantibodies,” Journal of Clinical Microbiology, vol. 44, no. 2, pp. 441–448, 2006. View at Publisher · View at Google Scholar · View at Scopus
  157. M. L. Sussman, L. Strauss, and H. L. Hodes, “Fatal coxsackie group B virus infection in the newborn; report of a case with necropsy findings and brief review of the literature,” American Journal of Diseases of Children, vol. 97, no. 4, pp. 483–492, 1959. View at Publisher · View at Google Scholar
  158. D. R. Gamble, M. L. Kinsley, M. G. FitzGerald, R. Bolton, and K. W. Taylor, “Viral antibodies in diabetes mellitus,” British Medical Journal, vol. 3, no. 671, pp. 627–630, 1969. View at Publisher · View at Google Scholar · View at Scopus
  159. L. Andreoletti, D. Hober, C. Hober-Vandenberghe et al., “Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type I diabetes mellitus,” Journal of Medical Virology, vol. 52, no. 2, pp. 121–127, 1997. View at Publisher · View at Google Scholar
  160. K. Sadeharju, A.-M. Hämäläinen, M. Knip et al., “Enterovirus infections as a risk factor for type I diabetes: virus analyses in a dietary intervention trial,” Clinical and Experimental Immunology, vol. 132, no. 2, pp. 271–277, 2003. View at Publisher · View at Google Scholar · View at Scopus
  161. S. Tauriainen, S. Oikarinen, M. Oikarinen, and H. Hyöty, “Enteroviruses in the pathogenesis of type 1 diabetes,” Seminars in Immunopathology, vol. 33, no. 1, pp. 45–55, 2011. View at Publisher · View at Google Scholar · View at Scopus
  162. L. Sarmiento, E. Cabrera-Rode, L. Lekuleni et al., “Occurrence of enterovirus RNA in serum of children with newly diagnosed type 1 diabetes and islet cell autoantibody-positive subjects in a population with a low incidence of type 1 diabetes,” Autoimmunity, vol. 40, no. 7, pp. 540–545, 2007. View at Publisher · View at Google Scholar · View at Scopus
  163. M. Karvonen, M. Viik-Kajander, E. Moltchanova, I. Libman, R. LaPorte, and J. Tuomilehto, “Incidence of childhood type 1 diabetes worldwide,” Diabetes Care, vol. 23, no. 10, pp. 1516–1526, 2000. View at Publisher · View at Google Scholar · View at Scopus
  164. J. W. Yoon, M. Austin, T. Onodera, and A. L. Notkins, “Virus-induced diabetes mellitus. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis,” The New England Journal of Medicine, vol. 300, no. 21, pp. 1173–1179, 1979. View at Publisher · View at Google Scholar · View at Scopus
  165. K. M. Drescher, K. Kono, S. Bopegamage, S. D. Carson, and S. Tracy, “Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: Insulitis determines susceptibility of pancreatic islets to virus infection,” Virology, vol. 329, no. 2, pp. 381–394, 2004. View at Publisher · View at Google Scholar · View at Scopus
  166. T. Kanno, K. Kim, K. Kono, K. M. Drescher, N. M. Chapman, and S. Tracy, “Group B coxsackievirus diabetogenic phenotype correlates with viral replication efficiency,” Journal of Virology, vol. 80, no. 11, pp. 5637–5643, 2006. View at Publisher · View at Google Scholar
  167. S. Tracy, K. M. Drescher, N. M. Chapman et al., “Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence,” Journal of Virology, vol. 76, no. 23, pp. 12097–12111, 2002. View at Publisher · View at Google Scholar · View at Scopus
  168. S. Oikarinen, S. Tauriainen, D. Hober et al., “Virus antibody survey in different european populations indicates risk association between coxsackievirus B1 and type 1 diabetes,” Diabetes, vol. 63, no. 2, pp. 655–662, 2014. View at Publisher · View at Google Scholar · View at Scopus
  169. O. H. Laitinen, H. Honkanen, O. Pakkanen et al., “Coxsackievirus B1 is associated with induction of β-cells autoimmunity that portends type 1 diabetes,” Diabetes, vol. 63, no. 2, pp. 446–455, 2014. View at Publisher · View at Google Scholar · View at Scopus
  170. S. Bopegamage, J. Precechtelova, L. Marosova et al., “Outcome of challenge with coxsackievirus B4 in young mice after maternal infection with the same virus during gestation,” FEMS Immunology & Medical Microbiology, vol. 64, no. 2, pp. 184–190, 2012. View at Publisher · View at Google Scholar · View at Scopus
  171. P. G. Larsson, T. Lakshmikanth, E. Svedin, C. King, and M. Flodström-Tullberg, “Previous maternal infection protects offspring from enterovirus infection and prevents experimental diabetes development in mice,” Diabetologia, vol. 56, no. 4, pp. 867–874, 2013. View at Publisher · View at Google Scholar · View at Scopus
  172. G. Frisk and H. Diderholm, “Tissue culture of isolated human pancreatic islets infected with different strains of Coxsackievirus B4: assessment of virus replication and effects on islet morphology and insulin release,” Experimental Diabesity Research, vol. 1, no. 3, pp. 165–175, 2000. View at Google Scholar · View at Scopus
  173. M. Roivainen, S. Rasilainen, P. Ylipaasto et al., “Mechanisms of coxsackievirus-induced damage to human pancreatic β-cells,” The Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 1, pp. 432–440, 2000. View at Publisher · View at Google Scholar · View at Scopus
  174. S. A. Bopegamage and A. Petrovicova, “In vitro infection of mouse pancreatic islet cells with coxsackie viruses,” Acta Virologica, vol. 38, no. 5, pp. 251–255, 1994. View at Google Scholar · View at Scopus
  175. H. Yin, A.-K. Berg, J. Westman, C. Hellerström, and G. Frisk, “Complete nucleotide sequence of a coxsackievirus B-4 strain capable of establishing persistent infection in human pancreatic islet cells: effects on insulin release, proinsulin synthesis, and cell morphology,” Journal of Medical Virology, vol. 68, no. 4, pp. 544–557, 2002. View at Publisher · View at Google Scholar · View at Scopus
  176. M. Roivainen, P. Ylipaasto, J. Ustinov, T. Hovi, and T. Otonkoshi, “Screening enteroviruses for β-cell tropism using foetal porcine β-cells,” Journal of General Virology, vol. 82, no. 8, pp. 1909–1916, 2001. View at Google Scholar · View at Scopus
  177. T. M. Szopa, D. R. Gamble, and K. W. Taylor, “Biochemical changes induced by Coxsackie B4 virus in short-term culture of mouse pancreatic islets,” Bioscience Reports, vol. 5, no. 1, pp. 63–69, 1985. View at Publisher · View at Google Scholar · View at Scopus
  178. N. Welsh, B. Margulis, L. A. Borg et al., “Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: implications for the pathogenesis of insulin-dependent diabetes mellitus,” Molecular Medicine, vol. 1, no. 7, pp. 806–820, 1995. View at Google Scholar · View at Scopus
  179. G. G. Dahlquist, J. E. Boman, and P. Juto, “Enteroviral RNA and IgM antibodies in early pregnancy and risk for childhood-onset IDDM in offspring,” Diabetes Care, vol. 22, no. 2, pp. 364–365, 1999. View at Publisher · View at Google Scholar · View at Scopus
  180. M. Elfving, J. Svensson, S. Oikarinen et al., “Maternal enterovirus infection during pregnancy as a risk factor in offspring diagnosed with type 1 diabetes between 15 and 30 years of age,” Experimental diabetes research, vol. 2008, pp. 271958–271964, 2008. View at Google Scholar · View at Scopus
  181. H. Viskari, J. Ludvigsson, R. Uibo et al., “Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variation,” Diabetologia, vol. 48, no. 7, pp. 1280–1287, 2005. View at Publisher · View at Google Scholar · View at Scopus
  182. H. R. Viskari, M. Roivainen, A. Reunanen et al., “Maternal first-trimester enterovirus infection and future risk of type 1 diabetes in the exposed fetus,” Diabetes, vol. 51, no. 8, pp. 2568–2571, 2002. View at Publisher · View at Google Scholar · View at Scopus
  183. R. Coutant, J. C. Carel, P. Lebon, L. Cantero-Aguilar, P. Lebon, and P. F. Bougnères, “Detection of enterovirus RNA sequences in serum samples from autoantibody-positive subjects at risk for diabetes,” Diabetic Medicine, vol. 19, no. 11, pp. 968–969, 2002. View at Publisher · View at Google Scholar
  184. G. Frisk and H. Diderholm, “Antibody responses to different strains of Coxsackie B4 virus in patients with newly diagnosed type I diabetes mellitus or aseptic meningitis,” Journal of Infection, vol. 34, no. 3, pp. 205–210, 1997. View at Publisher · View at Google Scholar · View at Scopus
  185. G. Frisk and T. Tuvemo, “Enterovirus infections with β-cell tropic strains are frequent in siblings of children diagnosed with type 1 diabetes children and in association with elevated levels of GAD65 antibodies,” Journal of Medical Virology, vol. 73, no. 3, pp. 450–459, 2004. View at Publisher · View at Google Scholar · View at Scopus
  186. M. M. Maha, M. A. Ali, S. E. Abdel-Rehim, E. A. Abu-Shady, B. M. El-Naggar, and Y. Z. Maha, “The role of coxsackieviruses infection in the children of insulin dependent diabetes mellitus.,” The Journal of the Egyptian Public Health Association, vol. 78, no. 3-4, pp. 305–318, 2003. View at Google Scholar · View at Scopus
  187. R. Varela-Calvino, R. Ellis, G. Sgarbi, C. M. Dayan, and M. Peakman, “Characterization of the T-cell response to coxsackievirus B4: evidence that effector memory cells predominate in patients with type 1 diabetes,” Diabetes, vol. 51, no. 6, pp. 1745–1753, 2002. View at Publisher · View at Google Scholar · View at Scopus
  188. L. C. Stene, S. Oikarinen, H. Hyöty et al., “Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY),” Diabetes, vol. 59, no. 12, pp. 3174–3180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  189. S. Oikarinen, M. Martiskainen, S. Tauriainen et al., “Enterovirus RNA in blood is linked to the development of type 1 diabetes,” Diabetes, vol. 60, no. 1, pp. 276–279, 2011. View at Publisher · View at Google Scholar · View at Scopus
  190. K. K. Salminen, T. Vuorinen, S. Oikarinen et al., “Isolation of enterovirus strains from children with preclinical Type 1 diabetes,” Diabetic Medicine, vol. 21, no. 2, pp. 156–164, 2004. View at Publisher · View at Google Scholar · View at Scopus
  191. G. G. Dahlquist, J. Forsberg, L. Hagenfeldt, J. Boman, and P. Juto, “Increased prevalence of enteroviral RNA in blood spots from newborn children who later developed type 1 diabetes: a population-based case-control study,” Diabetes Care, vol. 27, no. 1, pp. 285–286, 2004. View at Publisher · View at Google Scholar · View at Scopus
  192. G. B. Clements, D. N. Galbraith, and K. W. Taylor, “Coxsackie B virus infection and onset of childhood diabetes,” The Lancet, vol. 346, no. 8969, pp. 221–223, 1995. View at Publisher · View at Google Scholar · View at Scopus
  193. M. E. Craig, N. J. Howard, M. Silink, and W. D. Rawlinson, “Reduced frequency of HLA DRB1-03, DQB1-02 in children with type 1 diabetes associated with enterovirus RNA,” Journal of Infectious Diseases, vol. 187, no. 10, pp. 1562–1570, 2003. View at Publisher · View at Google Scholar
  194. H. Kawashima, T. Ihara, H. Ioi et al., “Enterovirus-related type 1 diabetes mellitus and antibodies to glutamic acid decarboxylase in Japan,” Journal of Infection, vol. 49, no. 2, pp. 147–151, 2004. View at Publisher · View at Google Scholar · View at Scopus
  195. C. Nairn, D. N. Galbraith, K. W. Taylor, and G. B. Clements, “Enterovirus variants in the serum of children at the onset oftype 1 diabetes mellitus,” Diabetic Medicine, vol. 16, no. 6, pp. 509–513, 1999. View at Publisher · View at Google Scholar · View at Scopus
  196. H. Yin, A.-K. Berg, T. Tuvemo, and G. Frisk, “Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset,” Diabetes, vol. 51, no. 6, pp. 1964–1971, 2002. View at Publisher · View at Google Scholar · View at Scopus
  197. A. Toniolo, G. Maccari, G. Federico et al., “Are enterovirus infections linked to the early stages of type 1 diabetes?” in Proceedings of the American Society for Microbiology Meeting, CA. Abst. ST-902, San Diego, Calif, USA, 2010.
  198. B. M. Schulte, J. Bakkers, K. H. W. Lanke et al., “Detection of enterovirus RNA in peripheral blood mononuclear cells of type 1 diabetic patients beyond the stage of acute infection,” Viral Immunology, vol. 23, no. 1, pp. 99–104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  199. H. Champsaur, E. Dussaix, D. Samolyk, M. Fabre, C. Bach, and R. Assan, “Diabetes and Coxsackie virus B5 infection,” The Lancet, vol. 315, no. 8162, p. 251, 1980. View at Publisher · View at Google Scholar · View at Scopus
  200. C. di Pietro, M. J. del Guercio, G. P. Paolino, M. Barbi, P. Ferrante, and G. Chiumello, “Type 1 diabetes and Coxsackie virus infection,” Helvetica Paediatrica Acta, vol. 34, no. 6, pp. 557–561, 1979. View at Google Scholar · View at Scopus
  201. P. Ylipaasto, K. Klingel, A. M. Lindberg et al., “Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells,” Diabetologia, vol. 47, no. 2, pp. 225–239, 2004. View at Publisher · View at Google Scholar · View at Scopus
  202. F. Dotta, S. Censini, A. G. S. van Halteren et al., “Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 12, pp. 5115–5120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  203. M. Oikarinen, S. Tauriainen, T. Honkanen et al., “Analysis of pancreas tissue in a child positive for islet cell antibodies,” Diabetologia, vol. 51, no. 10, pp. 1796–1802, 2008. View at Publisher · View at Google Scholar · View at Scopus
  204. S. J. Richardson, A. Willcox, A. J. Bone, A. K. Foulis, and N. G. Morgan, “The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes,” Diabetologia, vol. 52, no. 6, pp. 1143–1151, 2009. View at Publisher · View at Google Scholar · View at Scopus
  205. P. Ylipaasto, B. Kutlu, S. Rasilainen et al., “Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets,” Diabetologia, vol. 48, no. 8, pp. 1510–1522, 2005. View at Publisher · View at Google Scholar · View at Scopus
  206. D. P. Strachan, “Hay fever, hygiene, and household size,” British Medical Journal, vol. 299, no. 6710, pp. 1259–1260, 1989. View at Publisher · View at Google Scholar · View at Scopus
  207. J. F. Bach, “The effect of infections on susceptibility to autoimmune and allergic diseases,” The New England Journal of Medicine, vol. 347, no. 12, pp. 911–920, 2002. View at Publisher · View at Google Scholar · View at Scopus
  208. H. S. Lee, T. Briese, C. Winkler et al., “Next-generation sequencing for viruses in children with rapid-onset type 1 diabetes,” Diabetologia, vol. 56, no. 8, pp. 1705–1711, 2013. View at Publisher · View at Google Scholar · View at Scopus
  209. T. Boettler and M. Von Herrath, “Protection against or triggering of Type 1 diabetes? Different roles for viral infections,” Expert Review of Clinical Immunology, vol. 7, no. 1, pp. 45–53, 2011. View at Publisher · View at Google Scholar · View at Scopus
  210. N. M. Chapman, K. Coppieters, M. von Herrath, and S. Tracy, “The microbiology of human hygiene and its impact on type 1 diabetes,” Islets, vol. 4, no. 4, pp. 253–261, 2012. View at Publisher · View at Google Scholar · View at Scopus
  211. K. M. Drescher and S. Tracy, “The CVB and etiology of type 1 diabetes,” Current Topics in Microbiology and Immunology, vol. 323, pp. 259–274, 2008. View at Publisher · View at Google Scholar · View at Scopus
  212. H. Al-Hello, B. Davydova, T. Smura et al., “Phenotypic and genetic changes in coxsackievirus B5 following repeated passage in mouse pancreas in vivo,” Journal of Medical Virology, vol. 75, no. 4, pp. 566–574, 2005. View at Publisher · View at Google Scholar · View at Scopus
  213. M. Flodström, A. Maday, D. Balakrishna, M. M. Cleary, A. Yoshimura, and N. Sarvetnick, “Target cell defense prevents the development of diabetes after viral infection,” Nature Immunology, vol. 3, no. 4, pp. 373–382, 2002. View at Publisher · View at Google Scholar · View at Scopus
  214. G. Frisk, K. Jansson, M. Ericsson, and H. Diderholm, “Differences in inhibition of replication between Coxsackie B4 virus strains in various cell lines by antibodies to some cell surface proteins,” Virus Research, vol. 73, no. 2, pp. 121–130, 2001. View at Publisher · View at Google Scholar · View at Scopus
  215. T. M. Szopa, P. A. Titchener, N. D. Portwood, and K. W. Taylor, “Diabetes mellitus due to viruse—some recent developments,” Diabetologia, vol. 36, no. 8, pp. 687–695, 1993. View at Publisher · View at Google Scholar · View at Scopus
  216. E. Jaeckel, M. Manns, and M. von Herrath, “Viruses and diabetes,” Annals of the New York Academy of Sciences, vol. 958, pp. 7–25, 2002. View at Google Scholar · View at Scopus
  217. S. Skarsvik, J. Puranen, J. Honkanen et al., “Decreased in vitro type 1 immune response against coxsackie virus B4 in children with type 1 diabetes,” Diabetes, vol. 55, no. 4, pp. 996–1003, 2006. View at Publisher · View at Google Scholar · View at Scopus
  218. K. Klingel, S. Stephan, M. Sauter et al., “Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets,” Journal of Virology, vol. 70, no. 12, pp. 8888–8895, 1996. View at Google Scholar · View at Scopus
  219. B. O. Roep, H. S. Hiemstra, N. C. Schloot et al., “Molecular mimicry in type 1 diabetes: immune cross-reactivity between islet autoantigen and human cytomegalovirus but not Coxsackie virus,” Annals of the New York Academy of Sciences, vol. 958, pp. 163–165, 2002. View at Publisher · View at Google Scholar · View at Scopus
  220. M. A. Atkinson, M. A. Bowman, L. Campbell, B. L. Darrow, D. L. Kaufman, and N. K. Maclaren, “Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin-dependent diabetes,” The Journal of Clinical Investigation, vol. 94, no. 5, pp. 2125–2129, 1994. View at Publisher · View at Google Scholar · View at Scopus
  221. W. Richter, T. Mertens, B. Schoel et al., “Sequence homology of the diabetes-associated autoantigen glutamate decarboxylase with coxsackie B4-2C protein and heat shock protein 60 mediates no molecular mimicry of autoantibodies,” Journal of Experimental Medicine, vol. 180, no. 2, pp. 721–726, 1994. View at Publisher · View at Google Scholar · View at Scopus
  222. N. C. Schloot, S. J. M. Willemen, G. Duinkerken, J. W. Drijfhout, R. R. P. de Vries, and B. O. Roep, “Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to coxsackie or proinsulin peptides do not crossreact with homologous counterpart,” Human Immunology, vol. 62, no. 4, pp. 299–309, 2001. View at Publisher · View at Google Scholar · View at Scopus
  223. R. S. Fujinami, M. G. von Herrath, U. Christen, and J. L. Whitton, “Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease,” Clinical Microbiology Reviews, vol. 19, no. 1, pp. 80–94, 2006. View at Publisher · View at Google Scholar · View at Scopus
  224. M. S. Horwitz, A. Ilic, C. Fine, E. Rodriguez, and N. Sarvetnick, “Presented antigen from damaged pancreatic β cells activates autoreactive T cells in virus-mediated autoimmune diabetes,” Journal of Clinical Investigation, vol. 109, no. 1, pp. 79–87, 2002. View at Publisher · View at Google Scholar · View at Scopus
  225. G. R. Vreugdenhil, P. G. Wijnands, M. G. Netea, J. W. M. van der Meer, W. J. G. Melchers, and J. M. D. Galama, “Enterovirus-induced production of pro-inflammatory and T-helper cytokines by human leukocytes,” Cytokine, vol. 12, no. 12, pp. 1793–1796, 2000. View at Publisher · View at Google Scholar · View at Scopus
  226. G. R. Vreugdenhil, P. G. Wijnands, M. G. Netea et al., “Coxsackie B virus induces TNF-α production in human pancreatic ductal cells,” in Enterovirus and Type 1 Diabetes Mellitus: Putative Pathogenic Pathways, G. R. Vreugdenhil, Ed., dissertation thesis, Print Panters Iskamp, Enschede, The Netherlands, 2001. View at Google Scholar
  227. M. S. Horwitz, A. Ilic, C. Fine, B. Balasa, and N. Sarvetnick, “Coxsackieviral-mediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of beta cells,” Clinical Immunology, vol. 110, no. 2, pp. 134–144, 2004. View at Publisher · View at Google Scholar · View at Scopus
  228. M. S. Horwitz, C. Fine, A. Ilic, and N. Sarvetnick, “Requirements for viral-mediated autoimmune diabetes: β-cell damage and immune infiltration,” Journal of Autoimmunity, vol. 16, no. 3, pp. 211–217, 2001. View at Publisher · View at Google Scholar · View at Scopus
  229. D. Hober, W. Chehadeh, J. Weill et al., “Circulating and cell-bound antibodies increase coxsackievirus B4-induced production of IFN-α by peripheral blood mononuclear cells from patients with type 1 diabetes,” Journal of General Virology, vol. 83, no. 9, pp. 2169–2176, 2002. View at Google Scholar · View at Scopus
  230. W. Chehadeh, A. Bouzidi, G. Alm, P. Wattré, and D. Hober, “Human antibodies isolated from plasma by affinity chromatography increase the coxsackievirus B4-induced synthesis of interferon-α by human peripheral blood mononuclear cells in vitro,” Journal of General Virology, vol. 82, no. 8, pp. 1899–1907, 2001. View at Google Scholar · View at Scopus
  231. D. Hober, W. Chehadeh, A. Bouzidi, and P. Wattré, “Antibody-dependent enhancement of Coxsackievirus B4 infectivity of human peripheral blood mononuclear cells results in increased interferon-α synthesis,” Journal of Infectious Diseases, vol. 184, no. 9, pp. 1098–1108, 2001. View at Publisher · View at Google Scholar · View at Scopus
  232. P. Sauter, P.-E. Lobert, B. Lucas et al., “Role of the capsid protein VP4 in the plasma-dependent enhancement of the Coxsackievirus B4E2-infection of human peripheral blood cells,” Virus Research, vol. 125, no. 2, pp. 183–190, 2007. View at Publisher · View at Google Scholar · View at Scopus
  233. P. Sauter, W. Chehadeh, P.-E. Lobert et al., “A part of the VP4 capsid protein exhibited by coxsackievirus B4 E2 is the target of antibodies contained in plasma from patients with type 1 diabetes,” Journal of Medical Virology, vol. 80, no. 5, pp. 866–878, 2008. View at Publisher · View at Google Scholar · View at Scopus
  234. J. G. Rosmalen, W. van Ewijk, and P. J. Leenen, “T-cell education in autoimmune diabetes: teachers and students,” Trends in Immunology, vol. 23, no. 1, pp. 40–46, 2002. View at Publisher · View at Google Scholar · View at Scopus
  235. F. Brilot, H. Jaidane, V. Geenen, and D. Hober, “Coxsackievirus B4 infection of murine foetal thymus organ cultures,” Journal of Medical Virology, vol. 80, no. 4, pp. 659–666, 2008. View at Publisher · View at Google Scholar
  236. H. Jaïdane, J. Gharbi, P.-E. Lobert et al., “Prolonged viral RNA detection in blood and lymphoid tissues from Coxsackievirus B4 E2 orally-inoculated Swiss mice,” Microbiology and Immunology, vol. 50, no. 12, pp. 971–974, 2006. View at Publisher · View at Google Scholar · View at Scopus
  237. H. Jaïdane, P. Sauter, F. Sane, A. Goffard, J. Gharbi, and D. Hober, “Enteroviruses and type 1 diabetes: towards a better understanding of the relationship,” Reviews in Medical Virology, vol. 20, no. 5, pp. 265–280, 2010. View at Publisher · View at Google Scholar · View at Scopus
  238. O. Vaarala, “Leaking gut in type 1 diabetes,” Current Opinion in Gastroenterolgy, vol. 24, no. 6, pp. 701–706, 2008. View at Publisher · View at Google Scholar
  239. X. Xu, J. D'Hoker, G. Stangé et al., “β cells can be generated from endogenous progenitors in injured adult mouse pancreas,” Cell, vol. 132, no. 2, pp. 197–207, 2008. View at Publisher · View at Google Scholar · View at Scopus
  240. S. Bonner-Weir, “β-cell turnover: its assessment and implications,” Diabetes, vol. 50, no. 1, pp. S20–S24, 2001. View at Publisher · View at Google Scholar · View at Scopus
  241. M. Almgren, T. Schlinzig, D. Gomez-Cabrero et al., “Cesarean delivery and hematopoietic stem cell epigenetics in the newborn infant: implications for future health?” The American Journal of Obstetric and Gynecology, vol. 211, no. 5, pp. 502.e1–502.e8, 2014. View at Publisher · View at Google Scholar